Research
The scaffolding of expertise: rethinking capability formation in an AI-enabled system
Recent reporting from Accenture, Jisc, and the Institute of Student Employers points to a subtle but consequential shift in early-career development. While large-scale entry-level job loss has not yet materialised, a quieter change may already be underway: growing uncertainty about how ...
A weekend in Cambridge - Exclusive for families and partners of The University Arms and Cambridge Network
University Arms Cambridge is opening its doors to the families and guests of our corporate partners. Indulge with 30% off B&B on Friday, Saturday, and Sunday nights, a welcome drink on arrival, and breakfast included. Available by invitation only. Email [email protected] to...
CamAWiSE Annual General Meeting 2026
At the Annual General Meeting (AGM), we will elect the following leadership roles: Chair, Deputy Chair, Secretary, and Treasurer. Anyone can attend and submit nominations, but only members of CamAWiSE can vote in the election of roles. Role descriptions and nomination forms can be foun...
New Technologies and Building Successful Biotechnology Companies to Treat Disease
This event will explore how fundamental scientific discovery can be translated into real‑world benefit and the role universities play in supporting that journey with integrity, responsibility, and long‑term vision. ...
The Art of Floristry
Spring low arrangement workshop with expert florists. Includes seasonal blooms, vessel & fizz. Create and take home your own elegant design ...
Clement Mind presents at UKABIF 2026: Managing Challenging Behaviours after Acquired Brain Injury
Dr Alberto Bonilla Miralles, Clinical & Occupational Psychologist and Director at Clement Mind, delivered a specialist presentation at the UK Acquired Brain Injury Forum (UKABIF) on evidence-based approaches to understanding and managing challenging behaviours following an acquired ...
Nature loss brings catastrophic risks – ARU report
Food security is under threat, which could lead to economic and social instability. ...
Weight loss drugs boom drives pharma R&D returns, but industry could face ‘bubble’ effect
Top global pharma companies’ return on R&D increased for third consecutive year; Growth is almost entirely driven by GLP-1 drugs - used to treat obesity and diabetes - and accounts for 38% of projected sales;Obesity drugs have displaced oncology drugs as the largest contributor to t...
AVEVA to invest c.£30million in Cambridge Research and Development hub to support future growth
Global industrial software leader to consolidate its Cambridge teams at Science Park global HQ ahead of a 2027 opening, reinforcing its long-term commitment to the city and its Industrial Intelligence strategy. ...
12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033
This month Gene Scope Intelligence (www.genescope-intelligence.com), a dedicated gene therapy market intelligence platform releases a brand new commercial analysis and demand forecast for new gene therapies directed at Retinitis Pigmentosa (RP). ...